Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sze-Ue Luk"'
Autor:
Sze-Ue Luk, Terence Kin-Wah Lee, Ji Liu, Davy Tak-Wing Lee, Yung-Tuen Chiu, Stephanie Ma, Irene Oi-Lin Ng, Yong-Chuan Wong, Franky Leung Chan, Ming-Tat Ling
Publikováno v:
PLoS ONE, Vol 6, Iss 6 (2011)
Externí odkaz:
https://doaj.org/article/a2133b58113a44bea96cfb4e6d060ee5
Autor:
Sze-Ue Luk, Terence Kin-Wah Lee, Ji Liu, Davy Tak-Wing Lee, Yung-Tuen Chiu, Stephanie Ma, Irene Oi-Lin Ng, Yong-Chuan Wong, Franky Leung Chan, Ming-Tat Ling
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19804 (2011)
Recent evidence suggested that prostate cancer stem/progenitor cells (CSC) are responsible for cancer initiation as well as disease progression. Unfortunately, conventional therapies are only effective in targeting the more differentiated cancer cell
Externí odkaz:
https://doaj.org/article/5ef2290c5c0348ea9bb63341bc6696d1
Autor:
Yuzhuo Wang, Peter W. Gout, Martin E. Gleave, Amina Zoubeidi, Colin C. Collins, Xin Dong, Rebecca Wu, Anne Haegert, Dong Lin, Fang Zhang, Yuwei Wang, Hui Xue, Raunak Shrestha, Iris Sze Ue Luk
Serum PSA (ng/ml) per unit tumour volume (mm3) in individual mice and in Scrb and ASO-6w2 groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::966fd598bf7b7c05f08923db58c12c2d
https://doi.org/10.1158/1078-0432.22464486.v1
https://doi.org/10.1158/1078-0432.22464486.v1
Autor:
Yuzhuo Wang, Peter W. Gout, Martin E. Gleave, Amina Zoubeidi, Colin C. Collins, Xin Dong, Rebecca Wu, Anne Haegert, Dong Lin, Fang Zhang, Yuwei Wang, Hui Xue, Raunak Shrestha, Iris Sze Ue Luk
Gene expression changes in matrisome genesets associated with ASO-6w2 treatment of LTL-313BR xenografts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9e4b7c9c217871aa5b91e23265b095
https://doi.org/10.1158/1078-0432.22464507.v1
https://doi.org/10.1158/1078-0432.22464507.v1
Autor:
Yuzhuo Wang, Peter W. Gout, Martin E. Gleave, Amina Zoubeidi, Colin C. Collins, Xin Dong, Rebecca Wu, Anne Haegert, Dong Lin, Fang Zhang, Yuwei Wang, Hui Xue, Raunak Shrestha, Iris Sze Ue Luk
Purpose: Enzalutamide resistance has emerged as a major problem in the management of castration-resistant prostate cancer (CRPC). Research on therapy resistance of CRPCs has primarily focused on the androgen receptor pathway. In contrast, there is li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804292a6b206e8ec52505c84e81bd8f5
https://doi.org/10.1158/1078-0432.c.6525729
https://doi.org/10.1158/1078-0432.c.6525729
Autor:
Yuzhuo Wang, Peter W. Gout, Martin E. Gleave, Amina Zoubeidi, Colin C. Collins, Xin Dong, Rebecca Wu, Anne Haegert, Dong Lin, Fang Zhang, Yuwei Wang, Hui Xue, Raunak Shrestha, Iris Sze Ue Luk
Supplementary figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ab328060217248056f2d3dfdeddabf4
https://doi.org/10.1158/1078-0432.22464480
https://doi.org/10.1158/1078-0432.22464480
Autor:
Rebecca Wu, Hui Xue, Martin E. Gleave, Raunak Shrestha, Peter W. Gout, Yuwei Wang, Yuzhuo Wang, Dong Lin, Iris Sze Ue Luk, Amina Zoubeidi, Anne Haegert, Xin Dong, Fang Zhang, Colin Collins
Publikováno v:
Clinical Cancer Research. 23:1542-1551
Purpose: Enzalutamide resistance has emerged as a major problem in the management of castration-resistant prostate cancer (CRPC). Research on therapy resistance of CRPCs has primarily focused on the androgen receptor pathway. In contrast, there is li
Autor:
Yick-Pang Ching, Colleen C. Nelson, Wei Ney Yap, Ming-Tat Ling, Yee Leng Yap, Sze Ue Luk, Stephanie Ma, Terence Kin Wah Lee, Yung-Tuen Chiu, Yong-Chuan Wong, Raja S. Vasireddy, Davy Tak-Wing Lee
Publikováno v:
International Journal of Cancer. 128:2182-2191
Emerging evidence supports that prostate cancer originates from a rare subpopulation of cells, namely prostate cancer stem cells (CSCs). Conventional therapies for prostate cancer are believed to mainly target the majority of differentiated tumor cel
Autor:
Yuzhuo Wang, Ladan Fazli, Christopher G. Low, Kuo Yang, Yong Xu, Iris Sze Ue Luk, Dong Lin, Peter W. Gout, Martin E. Gleave
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 2, p e55837 (2013)
PLoS ONE, Vol 8, Iss 2, p e55837 (2013)
Background BIRC6 is a member of the Inhibitors of Apoptosis Protein (IAP) family which is thought to protect a variety of cancer cells from apoptosis. The main objective of the present study was to investigate whether BIRC6 plays a role in prostate c